Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951775 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cytochrome P450, Family 1, Subfamily A, Polypeptide 2 (CYP1A2) (Center) antibody
- Antibody type
- Polyclonal
- Antigen
- Other
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Vial size
- 0.1 mg
Submitted references Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine.
Probabilistic density maps to study global endomembrane organization.
Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.
The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients.
Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.
Gentile G, Borro M, Lala N, Missori S, Simmaco M, Martelletti P
The journal of headache and pain 2010 Oct;11(5):431-5
The journal of headache and pain 2010 Oct;11(5):431-5
Probabilistic density maps to study global endomembrane organization.
Schauer K, Duong T, Bleakley K, Bardin S, Bornens M, Goud B
Nature methods 2010 Jul;7(7):560-6
Nature methods 2010 Jul;7(7):560-6
Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.
Wang X, Yeung JH
The Journal of pharmacy and pharmacology 2010 Aug;62(8):1077-83
The Journal of pharmacy and pharmacology 2010 Aug;62(8):1077-83
The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients.
Uslu A, Ogus C, Ozdemir T, Bilgen T, Tosun O, Keser I
BMB reports 2010 Aug;43(8):530-4
BMB reports 2010 Aug;43(8):530-4
Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.
Jiang Z, Dragin N, Jorge-Nebert LF, Martin MV, Guengerich FP, Aklillu E, Ingelman-Sundberg M, Hammons GJ, Lyn-Cook BD, Kadlubar FF, Saldana SN, Sorter M, Vinks AA, Nassr N, von Richter O, Jin L, Nebert DW
Pharmacogenetics and genomics 2006 May;16(5):359-67
Pharmacogenetics and genomics 2006 May;16(5):359-67
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of CYP1A2 Antibody (Center) Cat.-No AP51164PU-N in Mouse liver tissue lysates (35ug/lane). This demonstrates the CYP1A2 antibody detected the CYP1A2 protein (arrow).
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Confocal immunofluorescent analysis of CYP1A2 Antibody (Center) Cat.-No AP51164PU-N f with 293 cell followed by Alexa Fluor®488-conjugated Goat anti-Rabbit lgG (green). DAPI was used to stain the cell nuclear (blue).
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Formalin fixed, paraffin embedded Human liver tissue stained with CYP1A2 Antibody (Center) Cat.-No AP51164PU-N followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of CYP1A2 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.
